Milan, Italy

Marc'Antonio Parenti

This inventor holds 1 USPTO granted patent. Top assignee: Carlo Erba. Active years: 1977.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marc'Antonio Parenti: Innovator in Pharmaceutical Chemistry

Introduction

Marc'Antonio Parenti is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyrazine derivatives. His research has implications for the development of new therapeutic compounds.

Latest Patents

Marc'Antonio Parenti holds a patent for "Pyrazine 4-oxide derivatives and process for their preparation." This patent includes compounds of the formula wherein R¹, R², and R³ can be hydrogen, C₁-₆ alkyl, or alkoxy, with at least one of R¹, R², and R³ being other than hydrogen. Additionally, R⁴ is described as carboxy, carbalkoxy, or a carboxamide group, or a pharmaceutically acceptable salt when R⁴ is carboxy. This innovation showcases his expertise in creating valuable chemical compounds.

Career Highlights

Marc'Antonio Parenti is associated with Carlo Erba, a company known for its contributions to the pharmaceutical industry. His work at Carlo Erba has allowed him to focus on the synthesis and application of novel chemical compounds, enhancing the company's research capabilities.

Collaborations

Throughout his career, Marc'Antonio has collaborated with esteemed colleagues such as Vittorio Ambrogi and Willy Logemann. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

Marc'Antonio Parenti's contributions to pharmaceutical chemistry through his patent and collaborations highlight his role as an influential inventor. His work continues to impact the development of new therapeutic agents, showcasing the importance of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…